These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24577910)

  • 1. Development and in vitro characterization of mebendazole delayed release tablet for colonic drug delivery.
    Baviskar D; Rajput A; Bare K; Biranwar Y; Chaudhari H; Narkhede D; Jain D
    Pak J Pharm Sci; 2014 Mar; 27(2):249-53. PubMed ID: 24577910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic evaluation of guar gum-based colon-targeted drug delivery systems of mebendazole in healthy volunteers.
    Krishnaiah YS; Veer Raju P; Dinesh Kumar B; Satyanarayana V; Karthikeyan RS; Bhaskar P
    J Control Release; 2003 Feb; 88(1):95-103. PubMed ID: 12586507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of colon targeted drug delivery systems for mebendazole.
    Krishnaiah YS; Veer Raju P; Dinesh Kumar B; Bhaskar P; Satyanarayana V
    J Control Release; 2001 Nov; 77(1-2):87-95. PubMed ID: 11689262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on maize proteins as a potential new tablet excipient.
    Georget DM; Barker SA; Belton PS
    Eur J Pharm Biopharm; 2008 Jun; 69(2):718-26. PubMed ID: 18294824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and evaluation of floating tablet of H2-receptor antagonist.
    Kesarla RS; Vora PA; Sridhar BK; Patel G; Omri A
    Drug Dev Ind Pharm; 2015; 41(9):1499-511. PubMed ID: 25243639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of chitosan acetate as a binder for sustained release tablets.
    Nunthanid J; Laungtana-Anan M; Sriamornsak P; Limmatvapirat S; Puttipipatkhachorn S; Lim LY; Khor E
    J Control Release; 2004 Sep; 99(1):15-26. PubMed ID: 15342177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and evaluation of Ficus glomerata mucilage sustained release matrix tablets of gliclazide.
    Kumar CS; Reddy-Budideti KK; Battula SP; Ayyavala CS
    Pak J Pharm Sci; 2011 Jul; 24(3):399. PubMed ID: 21715275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxymethyl starch and lecithin complex as matrix for targeted drug delivery: I. Monolithic mesalamine forms for colon delivery.
    Mihaela Friciu M; Canh Le T; Ispas-Szabo P; Mateescu MA
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):521-30. PubMed ID: 23562535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine.
    Kotagale N; Maniyar M; Somvanshi S; Umekar M; Patel CJ
    Pharm Dev Technol; 2010; 15(4):431-7. PubMed ID: 20236031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on stercuia gum formulations in the form of osmotic core tablet for colon-specific drug delivery of azathioprine.
    Nath B; Nath LK
    PDA J Pharm Sci Technol; 2013; 67(2):172-84. PubMed ID: 23569078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation development and in vitro evaluation of solidified self-microemulsion in the form of tablet containing atorvastatin calcium.
    Ali KA; Mukherjee B; Bandyopadhyay AK
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1742-9. PubMed ID: 23216220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of sustained-release matrix tablets of BKP-01-041 (tilorone derivative) containing Hypromellose.
    Chen L; Wang F
    Pharmazie; 2013 Oct; 68(10):796-9. PubMed ID: 24273882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excipient-excipient interaction in the design of sustained-release theophylline tablets: in vitro and in vivo evaluation.
    Bayomi MA; Al-Suwayeh SA; El-Helw AR
    Drug Dev Ind Pharm; 2001 Jul; 27(6):499-506. PubMed ID: 11548856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A; Ozkan Y; Işimer A
    Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronotherapeutic drug delivery of Tamarind gum, Chitosan and Okra gum controlled release colon targeted directly compressed Propranolol HCl matrix tablets and in-vitro evaluation.
    Newton AM; Indana VL; Kumar J
    Int J Biol Macromol; 2015 Aug; 79():290-9. PubMed ID: 25936283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a matrix tablet prepared with polyacrylamide-g-sodium alginate co-polymers and their partially hydrolyzed co-polymers for sustained release of diltiazem hydrochloride.
    Mandal S; Ray R; Basu SK; Sa B
    J Biomater Sci Polym Ed; 2010; 21(13):1799-814. PubMed ID: 20557689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on in vitro release empirical method and the release mechanism of budesonide colonic localization tablet].
    Liu H; Pan WS; Nie SF; Yang XG; Yan TX
    Yao Xue Xue Bao; 2008 Nov; 43(11):1147-51. PubMed ID: 19239036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysing the crystal purity of mebendazole raw material and its stability in a suspension formulation.
    Agatonovic-Kustrin S; Glass BD; Mangan M; Smithson J
    Int J Pharm; 2008 Sep; 361(1-2):245-50. PubMed ID: 18555626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of polymorph transformations that decrease the stability of tablets containing the WHO essential drug mebendazole.
    Brits M; Liebenberg W; de Villiers MM
    J Pharm Sci; 2010 Mar; 99(3):1138-51. PubMed ID: 19691117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD; Liu Y; Tang X; Zhang Q
    Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.